Oscar Health, Inc.
OSCR
$22.52
$0.371.67%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 47.42% | 49.35% | 56.71% | 68.52% | 79.78% |
| Total Other Revenue | -96.84% | -98.47% | -56.47% | -25.52% | 94.23% |
| Total Revenue | 45.77% | 46.95% | 54.62% | 67.06% | 79.94% |
| Cost of Revenue | 40.34% | 41.49% | 50.14% | 61.79% | 74.02% |
| Gross Profit | 69.17% | 72.24% | 74.73% | 93.00% | 110.84% |
| SG&A Expenses | 6.57% | 47.19% | 45.19% | 64.09% | 86.06% |
| Depreciation & Amortization | 58.15% | -- | -- | -- | -- |
| Other Operating Expenses | 0.24% | -23.07% | -8.47% | -3.27% | 6.11% |
| Total Operating Expenses | 30.41% | 33.16% | 40.96% | 52.31% | 65.48% |
| Operating Income | 95.48% | 60.06% | 44.45% | 23.25% | 0.25% |
| Income Before Tax | 91.04% | 56.19% | 40.77% | 20.63% | -2.40% |
| Income Tax Expenses | 12,042.11% | 729.83% | 4,079.01% | -22.20% | -101.36% |
| Earnings from Continuing Operations | 90.65% | 55.61% | 40.19% | 20.63% | -2.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -110.78% | -104.09% | -63.87% | -5.06% | -2.33% |
| Net Income | 90.61% | 55.35% | 40.13% | 20.66% | -2.15% |
| EBIT | 95.48% | 60.06% | 44.45% | 23.25% | 0.25% |
| EBITDA | 101.67% | 64.34% | 47.75% | 25.00% | 0.52% |
| EPS Basic | 90.33% | 57.53% | 41.74% | 22.48% | 0.13% |
| Normalized Basic EPS | 90.69% | 57.96% | 42.17% | 22.36% | -0.29% |
| EPS Diluted | 84.98% | 57.53% | 41.74% | 22.48% | 0.13% |
| Normalized Diluted EPS | 84.57% | 57.96% | 42.17% | 22.36% | -0.29% |
| Average Basic Shares Outstanding | 5.23% | 4.31% | 3.57% | 2.92% | 2.43% |
| Average Diluted Shares Outstanding | 12.51% | 4.31% | 3.57% | 2.92% | 2.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
